Latest News for: nephrology

Edit

Montréal to host World Congress of Nephrology: $14M in spinoffs for the metropolis Français

Canada Newswire 19 Aug 2025
Tomoko Takano, professor in the Department of Medicine at McGill University, Palais des congrès Ambassador and current president of the Canadian Society of Nephrology, WCN 2021 had to be held virtually due to the pandemic.
Edit

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

PR Newswire 31 Jul 2025
"Frenova's MyReason initiative and unparalleled expertise in nephrology, combined with Azenta's state-of-the-art genomic sequencing and sample management solutions, represent essential cornerstones of ...
Edit

New therapy teplizumab could delay type 1 diabetes by years – if caught early

The Conversation 08 Jul 2025
Dorde Krstic/Shutterstock.com. For more than a century, type 1 diabetes has meant one thing. a lifetime administering insulin ... Type 1 diabetes is an autoimmune condition that leads to complete loss of insulin production from the pancreas ... .
Edit

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

Nasdaq Globe Newswire 26 Jun 2025
... a virtual nephrology-focused key opinion leader (KOL) event on Monday, June 30, 2025 at 8.00 AM ET.
Edit

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

PR Newswire 25 Jun 2025
... the American Journal of Nephrology (AJN) highlighting the design and rationale of the Company's Phase 2 KOURAGE trial of lead candidate Auxora™ in acute kidney injury (AKI) with respiratory failure.
Edit

Nephrology Researchers – Ace Therapeutics Unveils Kidney Disease Preclinical Solutions to Power Up Renal Drug Development

GetNews 20 Jun 2025
New York, USA - June 20, 2025 - Ace Therapeutics, a leading preclinical research organization, unveils its specialized nephrology-focused preclinical solutions to accelerate kidney disease drug development.
Edit

VALIANT Phase 3 Data in Nephrology, 12 June (Swedish Orphan Biovitrum AB)

Public Technologies 13 Jun 2025
). Sobi's Aspaveli® and Phase 3 VALIANT data in Nephrology 52-week update. Conference call for investors and analysts. 12 June 2025. Agenda. Introduction C3G and IC-. MGN. Nicholas Webb ... VALIANT 52-week data. Fadi Fakhouri. MD PhD Professor of Nephrology ... 3 ... 5.
×